In a notable recognition bridging healthcare and broad societal impact, renowned liver specialist Dr. Chetan Kalal was honoured with the Dadasaheb Phalke Award 2025 (conferred by the Dadasaheb Phalke Chitrapat Union) for his outstanding contributions to hepatology, early diagnosis, and public health awareness.
While traditionally associated with cultural and artistic achievements, the platform expanded its recognition to honor medical leaders whose work significantly improves community welfare and preventive healthcare. Dr. Kalal’s honor underscores the growing importance of ethical medical communication, patient education, and scientific leadership in India.
A Pioneer in Medical Excellence
Dr. Chetan Kalal holds a distinguished position in Indian medicine as Maharashtra’s first DM Hepatologist. Trained at the prestigious Institute of Liver and Biliary Sciences (ILBS), New Delhi, he has spent over 18 years advancing care in liver diseases, liver transplantation, and complex gastrointestinal conditions.
- Clinical Breakthroughs: Specialist expertise in metabolic dysfunction-associated steatotic liver disease (MASLD/fatty liver), acute-on-chronic liver failure (ACLF), cirrhosis, and pre- and post-transplant management.
- Global Recognition: Two-time recipient of the prestigious American Association for the Study of Liver Diseases (AASLD) Young Investigator Award, with over 40 peer-reviewed research publications.
- Public Health Leadership: Active campaigner against the rising tide of fatty liver disease and promoter of lifestyle interventions, early fibrosis screening, and hepatitis prevention.
Bridging Clinical Care and Community Awareness
The Dadasaheb Phalke Award 2025 highlights Dr. Kalal's commitment to taking medical knowledge beyond hospital walls. Recognizing that lifestyle-driven liver conditions are rapidly increasing in India, his work focuses heavily on preventive care and public health literacy.
Focus Area
Traditional Clinical Approach
Dr. Chetan Kalal's Patient-Centric Model
Disease Intervention
Late-stage diagnosis and symptom management
Early non-invasive screening (FibroScan) and prevention
Patient Communication
Standard diagnostic reports and prescriptions
Accessible public education on metabolic and liver health
Treatment Strategy
Isolated organ treatment
Integrated care combining nutrition, lifestyle, and clinical therapy
Driving the Future of Liver Care in India
With metabolic disorders and fatty liver disease emerging as major health challenges nationwide, Dr. Kalal's recognition serves as a reminder of the vital role specialized medicine plays in public well-being. By uniting scientific rigor with compassionate, accessible patient communication, his efforts continue to shape higher standards in Indian hepatology.
